Hedge Fund - Farallon Capital
Boston Scientific Corp (BSX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $709,362,427 | 3.35% | 7,439,564 | $98.04 |
| 2 | 2025 - Q3 (2025-09-30) | $463,406,360 | 1.9% | 4,746,557 | $103.56 |
| 3 | 2025 - Q2 (2025-06-30) | $427,605,332 | 1.79% | 3,981,057 | $101.18 |
| 4 | 2025 - Q1 (2025-03-31) | $379,586,926 | 1.82% | 3,762,757 | $100.70 |
| 5 | 2024 - Q4 (2024-12-31) | $448,650,519 | 1.96% | 5,022,957 | $88.03 |
| 6 | 2024 - Q3 (2024-09-30) | $454,670,057 | 1.99% | 5,425,657 | $78.83 |
| 7 | 2024 - Q2 (2024-06-30) | $316,446,181 | 1.35% | 4,109,157 | $73.20 |
| 8 | 2024 - Q1 (2024-03-31) | $314,825,038 | 1.33% | 4,596,657 | $64.30 |
| 9 | 2023 - Q4 (2023-12-31) | $336,469,057 | 1.53% | 5,820,257 | $53.38 |
| 10 | 2023 - Q3 (2023-09-30) | $266,072,770 | 1.24% | 5,039,257 | $52.45 |
| 11 | 2023 - Q2 (2023-06-30) | $272,897,951 | 1.36% | 5,045,257 | $52.23 |
| 12 | 2023 - Q1 (2023-03-31) | $385,494,008 | 2.1% | 7,705,257 | $47.13 |
| 13 | 2022 - Q4 (2022-12-31) | $428,472,091 | 2.53% | 9,260,257 | $43.30 |
| 14 | 2022 - Q3 (2022-09-30) | $470,618,000 | 0.03% | 12,151,257 | $40.12 |
| 15 | 2022 - Q2 (2022-06-30) | $560,811,000 | 0.05% | 15,047,257 | $40.71 |
| 16 | 2022 - Q1 (2022-03-31) | $697,136,000 | 0.11% | 15,740,257 | $43.34 |
| 17 | 2021 - Q4 (2021-12-31) | $714,283,000 | 0.28% | 16,814,581 | $42.02 |
| 18 | 2021 - Q3 (2021-09-30) | $607,572,000 | 0.29% | 14,002,581 | $44.24 |
| 19 | 2021 - Q2 (2021-06-30) | $543,763,000 | 0.31% | 12,716,619 | $42.07 |
| 20 | 2021 - Q1 (2021-03-31) | $495,604,000 | 2.46% | 12,822,869 | $37.85 |
| 21 | 2020 - Q4 (2020-12-31) | $475,918,000 | 2.86% | 13,238,319 | $36.04 |
| 22 | 2020 - Q3 (2020-09-30) | $316,223,000 | 2.18% | 8,275,919 | $38.53 |
The displayed share prices are average quarterly stock market prices.